In 2023, Italy's exports of Basic Pharmaceutical Products and Pharmaceutical Preparations to Indonesia stood at 22.356 million USD. This represents a slight year-on-year increase of 0.62% from 2022. Over the last two years, exports have shown marginal growth following an 8.51% decline in 2022. The last five years have demonstrated an average annual growth rate (CAGR) of 0.021%, indicating a highly volatile performance.
Looking forward, the forecast period from 2024 to 2028 anticipates a modest increase with a 0.4% CAGR. The projected total growth over the next five years is expected to be around 2%, reaching 23.114 million USD by 2028. Although the forecast suggests a stabilizing trend, growth remains cautious and incremental.
Future trends to watch for include potential shifts due to regulatory changes, market access improvements, and healthcare demand in Indonesia. An increased focus on innovation and strategic partnerships could also influence export dynamics.
